Extensive modeling-based bone formation after 2 months of romosozumab treatment: Results from the FRAME clinical trial

by Erik F. Eriksen, Roland Chapurlat, Rogely Boyce, Jacques P. Brown, Stéphane Horlait, Cesar Libanati, Yifei Shi, Rachel B. Wagman, Pascale Chavassieux
Published 2020-10-01

Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study

by Jonathan D. Adachi, Henry G. Bone, Nadia S. Daizadeh, Paula Dakin, Socrates Papapoulos, Peyman Hadji, Chris Recknor, Michael A. Bolognese, Andrea Wang, Celia J. F. Lin, Rachel B. Wagman, Serge Ferrari
Published 2017-04-01